HLA MOLECULES IN BASAL-CELL CARCINOMA OF THE SKIN

被引:20
作者
CABRERA, T
GARRIDO, V
CONCHA, A
MARTIN, J
ESQUIVIAS, J
OLIVA, MR
RUIZCABELLO, F
SERRANO, S
GARRIDO, F
机构
[1] HOSP VIRGEN NIEVES, SERV ANAL CLIN & INMUNOL, AVD CORONEL MUNOZ 2, E-19014 GRANADA, SPAIN
[2] HOSP VIRGEN NIEVES, SERV ANAT PATOL, E-19014 GRANADA, SPAIN
[3] CSIC, INST PARASITOL, GRANADA, SPAIN
[4] UNIV GRANADA, HOSP CLIN, SERV DERMATOL, GRANADA, SPAIN
关键词
D O I
10.1016/S0171-2985(11)80086-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fifty basal cell carcinomas (BCC) and 8 samples of healthy skin were studied for HLA class I and class II antigen expression and for the presence of mutations in codon 12 of the K-ras and H-ras genes. All samples of healthy skin and of epithelium near the tumor showed high levels of class I molecules, whereas 38 % of the tumors showed complete absence. Sixty-two percent of the tumors presented positive class I expression with heterogeneous staining. These losses were due to the simultaneous lack of heavy chain and beta2-Microglobulin. Selective losses of HLA-A or HLA-B antigens were not detected. Class II antigens were absent in most of the tumors, only two tumors showing a few weakly positive cells with anti-HLA-DR mAb. The loss of class I expression correlated significantly with the degree of histological differentiation and aggressiveness. We were unable to correlate class I expression with clinical size, depth of invasion or the extent of leukocytic infiltrate surrounding the tumor. Analysis by PCR amplification of codon 12 of the K-ras and H-ras oncogenes detected H-ras mutations in 1 out of 50 cases, and no K-ras mutations in any of the tumors studied. Thus, a positive relationship between K-ras and H-ras mutations and BCC tumorigenesis or MHC alterations seems unlikely in this neoplasia.
引用
收藏
页码:440 / 452
页数:13
相关论文
共 46 条
[1]  
ALON Y, 1987, CANCER RES, V47, P2553
[2]   PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[3]   ROLE OF MHC GENE-PRODUCTS IN IMMUNE REGULATION [J].
BENACERRAF, B .
SCIENCE, 1981, 212 (4500) :1229-1238
[4]   THE MOLECULAR-GENETICS OF CANCER [J].
BISHOP, JM .
SCIENCE, 1987, 235 (4786) :305-311
[5]   PHENOTYPIC DYNAMICS OF TUMOR PROGRESSION IN HUMAN-MALIGNANT MELANOMA [J].
BROCKER, EB ;
SUTER, L ;
BRUGGEN, J ;
RUITER, DJ ;
MACHER, E ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (01) :29-35
[6]   HLA-DR ANTIGEN EXPRESSION IN PRIMARY MELANOMAS OF THE SKIN [J].
BROCKER, EB ;
SUTER, L ;
SORG, C .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 82 (03) :244-247
[7]   STIMULATION OF HLA-A,B,C BY IFN-ALPHA - THE DERIVATION OF MOLT-4 VARIANTS AND THE DIFFERENTIAL EXPRESSION OF HLA-A,B,C SUBSETS [J].
BURRONE, OR ;
KEFFORD, RF ;
GILMORE, D ;
MILSTEIN, C .
EMBO JOURNAL, 1985, 4 (11) :2855-2860
[8]   CHARACTERIZATION OF MONOCLONAL-ANTIBODIES DIRECTED AGAINST HLA CLASS-II MOLECULES [J].
CABRERA, T ;
RUIZCABELLO, F ;
LOPEZ, MA ;
DELAHIGUERA, B ;
SANCHEZ, M ;
GARRIDO, F .
HYBRIDOMA, 1986, 5 (03) :191-197
[9]   LOSS OF HLA HEAVY-CHAIN AND BETA-2-MICROGLOBULIN IN HLA NEGATIVE TUMORS [J].
CABRERA, T ;
CONCHA, A ;
RUIZCABELLO, F ;
GARRIDO, F .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 34 (02) :147-152
[10]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229